Erica Vigiani

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives

K. Varani, F. Vincenzi, D. Dal Ben, 2022, Pharmaceuticals.

Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists

K. Varani, F. Vincenzi, Silvia Pasquini, 2020, Pharmaceuticals.

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression

G. Marucci, M. Buccioni, C. Ghelardini, 2021, Pharmaceuticals.

CK1 delta inhibition: an emerging strategy to combat neurodegenerative diseases.

D. Catarzi, V. Colotta, F. Varano, 2022, Future medicinal chemistry.